Sana Biotechnology Inc expected to post a loss of 43 cents a share - Earnings Preview

Sana Biotechnology

31/07/2023 13:06

* Sana Biotechnology Inc  SANA.OQ   SANA.O  is expected
to show no
change in quarterly revenue when it reports  results on August 2
(estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Sana Biotechnology
Inc is
for a loss of 43 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had risen by
about 9.8%
in the last three months. ​
    * Wall Street's median 12-month price target for Sana
Biotechnology Inc is $11​, above​ its last closing price
of $5.82. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  -0.42       -0.45      -0.43     Beat    3.7
 Dec. 31 2023  -0.51       -0.51      -0.38     Beat    26.2
 Sep. 30 2022  -0.53       -0.53      -0.45     Beat    15.1​
 Jun. 30 2022  -0.51       -0.51      -0.39     Beat    23
 ​​Mar.        -0.47       -0.47      -0.47     Met     0.7
 31 2022                                                
 Dec. 31 2021              -0.55      -0.60     Missed  -8.1​
 Sep. 30 2021  -0.46       -0.49      -0.46     Beat    6.8
 Jun. 30 2021  -0.44       -0.45      -0.32     Beat    28.9
 This summary was machine generated July 31 at 12:05 GMT.  All
figures in US dollars  unless otherwise stated